Troendle August J. 4
4 · Medpace Holdings, Inc. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
Troendle August J.
DirectorCEO10% Owner
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-03-06+73,443→ 73,443 totalExercise: $325.73Exp: 2034-03-06→ Common Stock (73,443 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-03-07−234,259→ 0 totalExercise: $56.61From: 2019-05-02Exp: 2026-05-02→ Common Stock (234,259 underlying) - Exercise/Conversion
Common Stock
2025-03-07$56.61/sh+234,259$13,261,402→ 926,332 total - Exercise/Conversion
Common Stock
2025-03-07$54.74/sh+37,417$2,048,207→ 692,073 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-03-07−37,417→ 0 totalExercise: $54.74From: 2019-03-01Exp: 2026-03-01→ Common Stock (37,417 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-03-07−84,770→ 0 totalExercise: $107.93From: 2020-02-28Exp: 2026-02-28→ Common Stock (84,770 underlying) - Exercise/Conversion
Common Stock
2025-03-07$107.93/sh+84,770$9,149,226→ 1,011,102 total
Holdings
- 4,733,019(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F2]The option vests immediately upon issuance.